Pular para o conteúdo

Interações medicamentosas

Empagliflozin-linagliptin + Fosphenytoin

Gravidade: Grave

Empagliflozin-linagliptin and Fosphenytoin: major interaction.

Última atualização

Para profissionais de saúde — apenas referência. Esta página é um resumo breve, não é aconselhamento médico nem substitui a bula oficial ou o julgamento clínico. Verifique sempre antes de prescrever ou dispensar.

O conteúdo clínico desta página está disponível apenas em inglês.

Resumo

Fosphenytoin is converted to phenytoin, a strong inducer of CYP3A4 and P-glycoprotein, which can substantially lower linagliptin exposure. Loss of linagliptin effect may lead to worsened glycemic control.

O que esta interação significa em palavras simples

Empagliflozin-linagliptin and Fosphenytoin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Empagliflozin-linagliptin belongs to Endocrine; Fosphenytoin belongs to Central Nervous System.

Nível de evidência: Moderate

Por que acontece

Phenytoin induces CYP3A4 and P-glycoprotein, increasing linagliptin clearance.

O que fazer

Linagliptin labeling advises an alternative to strong inducers; use a different antidiabetic agent where possible, otherwise monitor glucose and HbA1c closely.

O que perguntar ao farmacêutico

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Para assinantes do Pro+

Desbloqueie a página completa

Crie uma conta e comece um teste do Pro+ para desbloquear a orientação completa de conduta para Empagliflozin-linagliptin e Fosphenytoin, as notas adicionais, os detalhes da evidência e o verificador de interações para uma prescrição completa.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Experimente o Pro+ grátis por 14 dias na web. Sem cartão.

Perguntas frequentes

Can I take Empagliflozin-linagliptin with Fosphenytoin?

MediHelp rates the interaction as major. Empagliflozin-linagliptin and Fosphenytoin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Fosphenytoin is converted to phenytoin, a strong inducer of CYP3A4 and P-glycoprotein, which can substantially lower linagliptin exposure. Loss of linagliptin effect may lead to worsened glycemic control.

How serious is the interaction between Empagliflozin-linagliptin and Fosphenytoin?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Linagliptin labeling advises an alternative to strong inducers; use a different antidiabetic agent where possible, otherwise monitor glucose and HbA1c closely.

What other medicines interact with Empagliflozin-linagliptin?

MediHelp also lists interactions of Empagliflozin-linagliptin with, for example, Rifampin, Rifapentine, Amiloride. The full list is on the Empagliflozin-linagliptin page.

Monografias completas, posologia e verificador de interações no app MediHelp

Abra a referência completa, verifique interações entre vários medicamentos e use as ferramentas de posologia no app MediHelp.

Explorar de A a Z · Interações medicamentosas

Baixar o app Entrar